1. Home
  2. CMRC vs OABI Comparison

CMRC vs OABI Comparison

Compare CMRC & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commerce.com Inc.

CMRC

Commerce.com Inc.

HOLD

Current Price

$2.92

Market Cap

211.3M

Sector

N/A

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.44

Market Cap

237.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMRC
OABI
Founded
2009
2012
Country
United States
United States
Employees
1079
89
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.3M
237.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CMRC
OABI
Price
$2.92
$1.44
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$4.88
$4.50
AVG Volume (30 Days)
587.8K
555.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.11
$52.42
Revenue Next Year
$4.50
$64.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.41
$1.22
52 Week High
$5.55
$2.22

Technical Indicators

Market Signals
Indicator
CMRC
OABI
Relative Strength Index (RSI) 54.46 38.93
Support Level $2.43 $1.32
Resistance Level $3.10 $1.70
Average True Range (ATR) 0.19 0.09
MACD 0.04 0.00
Stochastic Oscillator 63.95 4.55

Price Performance

Historical Comparison
CMRC
OABI

About CMRC Commerce.com Inc.

Commerce.com Inc is engaged in offering a Software-as-a-Service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which the majority of its revenue is generated from Americas-U.S.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: